| 3AM9 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | BCT, CA, FAD, FES, FYO, GOL, MOS, MTE | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | FYX-051 : A novel and potent hybrid type inhibitor of xanthine oxidoreductase., Matsumoto K, Okamoto K, Ashizawa N, Nishino T, J Pharmacol Exp Ther. 2010 Oct 15. PMID:20952484 | ||||||||||||||
| Data retrieval |
![]() |
| View 3AM9 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |